Mentorship: ‘Shamelessly borrowing from the best’ BCPhA announces new boardSafeway exec to lead cast of new and returning directors. Health Canada finds atypical antipsychotics possibly linked to sleep apnea Product labelling for all atypical antipsychotics to be updated to highlight this risk. Prescription Transfers: Not so black and white Darwinian “survival of the fittest” marketing tactics will be our own demise if things don't change. Here are some ideas for a more professional, ethical way forward. Viscous lidocaine not recommended for teething pain Use linked to severe side effects in infants and young children. Business leader named NAPRA's new executive director Adele Fifield takes reins from outgoing executive director Carole Bouchard September 2nd. Newfoundland to provide naloxone kits to counter effects of opioid overdoses Initiative part of province's broader opioid action plan. Canada's move to control fentanyl chemicals not enough to stem crisis: expert Restricting chemicals used to make drug will increase demands for more dangerous replacement, say observers. Kroll integrating med sync program Dispensing software program to incorporate Ateb Canada’s Time My Meds platform. Medication review is essential after a fragility fracture Prescription drugs with increased fracture risk often continued after a fracture, and new high-risk drugs often started. First Previous 557 558 559 560 561 Next Last
